International scientific guideline: Production and quality control of medicinal products derived by recombinant DNA technology

About this guideline

Overseas effective date: 12 Feb 2002

Categories: Biological medicines | Drug substance | Manufacture and characterisation and control of the drug substance

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.